Burke Steven Keith — SEC Form 4 filings
SEC reporting owner CIK 1619834. 8 Form 4 filings on record with FilingPulse; latest filed 2026-02-04.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-02-02 to 2026-02-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 10 legs across 7 filings — 192,155 shares, $309,118 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
- Largest priced transaction: sale of 27,236 shares @ $2.10 ($57,196) in Akebia Therapeutics, Inc., filed 2025-02-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Akebia Therapeutics, Inc. (AKBA) | SVP, Chief Medical Officer | 8 | — | 10 legs · 192,155 sh · $309,118 | 6 |
Form 4 filings — Burke Steven Keith
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-04 | 4 | Akebia Therapeutics, Inc. (AKBA) | Sale (S): 21,582 @ $1.39 · Sale (S): 25,375 @ $1.39 · Sale (S): 20,701 @ $1.39 | EDGAR |
| 2026-02-03 | 4 | Akebia Therapeutics, Inc. (AKBA) | Grant/award (A): 204,000 @ $0 · Grant/award (A): 320,000 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Akebia Therapeutics, Inc. (AKBA) | Sale (S): 7,144 @ $1.83 | EDGAR |
| 2025-02-04 | 4 | Akebia Therapeutics, Inc. (AKBA) | Grant/award (A): 194,900 @ $0 · Sale (S): 23,270 @ $2.10 · Sale (S): 27,236 @ $2.10 · Grant/award (A): 292,300 (derivative) @ $0 | EDGAR |
| 2024-05-09 | 4 | Akebia Therapeutics, Inc. (AKBA) | Sale (S): 27,000 @ $1.15 | EDGAR |
| 2024-03-01 | 4 | Akebia Therapeutics, Inc. (AKBA) | Sale (S): 7,169 @ $1.58 | EDGAR |
| 2024-02-29 | 4 | Akebia Therapeutics, Inc. (AKBA) | Sale (S): 8,367 @ $1.52 | EDGAR |
| 2024-02-02 | 4 | Akebia Therapeutics, Inc. (AKBA) | Grant/award (A): 202,200 @ $0 · Sale (S): 24,311 @ $1.68 · Grant/award (A): 303,300 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1619834 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →